BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-5 out of 5 found
  Current Search:  muscle: 98, spasticity: 5     

HTML
58%
Medtronic Announces Two Worldwide Clinical Trials To Study Medical Device Interventions For Stroke
Each year, approximately 795,000 people experience a new or recurrent stroke1 in the United States, and approximately a half million people in Western Europe are similarly afflicted2.

Today, Medtronic, Inc.

(NYSE: MDT) announces two...

Medical News Today:  Jun 26 2009 11:55AM
Matching: spasticity
Find similar documents
HTML
58%
Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
people experience a new or recurrent stroke1 in the United States, and approximately a half million people in Western Europe are similarly afflicted2.

Today, Medtronic, Inc.

(NYSE: MDT) announces two significant clinical trials related...

Genetic Engineering News:  Jun 24 2009 3:25PM
Matching: spasticity
Find similar documents
HTML
58%
Allergan, Inc. - Allergan Receives Complete Response Letter for BOTOX Botulinum Toxin Type a for Treatment o
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA We're a pay-per-view site for premium content.

If you'd like to purchase this article, it's only $3.00.

Allergan, Inc.

Allergan Receives...

NewsRX:  Jun 9 2009 6:31PM
Matching: spasticity
Find similar documents
HTML
58%
FDA Delays Approval of Allergan Inc. (AGN)'s Botox to Treat Spasticity
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc.

(NYSE:AGN - News) today announced it has received a complete response letter from the U.S.

Food and Drug Administration (FDA) regarding the Companys Supplemental Biologics License...

BioSpace:  May 27 2009 2:32PM
Matching: spasticity
Find similar documents
HTML
58%
Almirall Announces Filing Sativex(R) - For Treatment Of Spasticity In Multiple Sclerosis - Regulatory Submissi
Almirall announces today that the file for a regulatory submission for Sativex for the treatment of spasticity due to multiple sclerosis has been submitted in UK and Spain under the European decentralised procedure.

The UK regulatory...

Medical News Today:  May 25 2009 12:34PM
Matching: spasticity
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.